This is the comparison of prescription sales for pharmacies open for business for at least twelve months, expressed as a percentage.
This metric is useful to determine what amount of new prescription sales comes from actual sales growth or merely from new pharmacy openings. If the comparable prescription sales growth is stagnant, but overall prescription sales are increasing for example, the sales growth can be attributed to new pharmacies instead of actual enhanced productivity.